Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Performance Testing of the Modified Electrocardiogram Lead Placement

19. Juli 2026 aktualisiert von: Hansu Bae

Performance Testing of the Modified Electrocardiogram Lead Placement in Patients Undergoing General Anesthesia

During general anesthesia for surgery, doctors use an electrocardiogram (ECG)-a simple heart monitor-to check for problems like poor blood flow to the heart or irregular heartbeats. Normally, ECG stickers (called electrodes) go on both shoulders and the left side of the belly, right outside the heart area, to get clear readings.

But for shoulder surgery, these spots are in the way of the operation, so doctors often place them elsewhere, like on the breastbone instead of the shoulder. This can give fuzzy or wrong results, missing key changes in the patient's heart-good or bad-during surgery.

To fix this and better watch heart health in shoulder surgery patients, this study tests different ECG sticker spots: the usual ones, the common backup (like on the breastbone), and a new idea-placing them near both temples. Researchers hope to find which setup gives the most accurate heart readings to keep patients safer.

Studienübersicht

Status

Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Background and Rationale Electrocardiogram (ECG) monitoring is essential during general anesthesia to assess heart rate, arrhythmias, and myocardial ischemia, alongside blood pressure. Standard Lead II, derived from limb leads placed on the torso (both clavicles below and left anterior superior iliac spine, outside the heart boundary), aligns best with the heart's electrical axis for accurate rhythm and ischemia detection. However, in shoulder surgeries like arthroscopic rotator cuff repair, surgical incisions overlap these sites, forcing electrode relocation (e.g., to the sternum instead of the shoulder). This inward shift distorts ECG signals, potentially missing normal or abnormal heart changes during surgery. To address this, modified Lead II placements are needed for reliable cardiac surveillance in shoulder surgery patients.

Study Overview This prospective, single-group interventional study evaluates the performance of two modified ECG Lead II configurations compared to the standard during general anesthesia for non-shoulder surgeries (to simulate placement feasibility). The modifications test alternative sites for the left shoulder electrode: sternum center (modified Sternum-Chest Lead II, mSC2) versus temple (modified Temple-Chest Lead II, mTC2). Left-side versions are assessed post-induction in supine position; right-side versions post-surgery. Outcomes focus on ST segment morphology similarity (visual and quantitative) to ensure modified leads maintain diagnostic accuracy without artifacts.

Methods Summary Eligible adults (19-65 years) scheduled for general anesthesia in non-shoulder sites undergo standard monitoring (ECG, NIBP, SpO2) per institutional protocols. After induction and hemodynamic stabilization, three ECG configurations are recorded simultaneously using Vital Recorder software (VitalDB, Republic of Korea) for at least 10 noise-free waves: (1) Standard Lead II; (2) Left mSC2 (sternum, right shoulder, left iliac spine); (3) Left mTC2 (left temple, right shoulder, left iliac spine). Post-surgery, right-side mSC2 and mTC2 are added. Recordings capture preoperative ST segment status (normal/abnormal). Blinded assessors (two researchers, third for ties) evaluate ST similarity visually; quantitative area differences use R/RStudio.

Statistical Considerations Sample size (n=84, 10% dropout) is calculated via McNemar test for paired comparisons, stratified by ST status (normal: 38 pairs; abnormal: 46 pairs), yielding 80% power at $\alpha=0.05$ based on pilot data. Analysis: Stratified McNemar for agreement; R for area differences.

Safety and Ethics Modifications involve brief additional recordings with no added risk beyond standard care. IRB-approved (Dongguk University Ilsan Hospital); informed consent obtained. Data anonymized (case numbers); stored securely for 3 years per regulations.

Studientyp

Interventionell

Einschreibung (Geschätzt)

84

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

  • Name: Dongkyu Lee, MD. Ph.D
  • Telefonnummer: 080-10-6431-4217
  • E-Mail: entopic@naver.com

Studienorte

  • Südkorea
    • Gyeonggi-do
      • Goyang-si, Gyeonggi-do, Südkorea, 10326
        • Rekrutierung
        • Dongguk University Il-san Hospital
        • Kontakt:
        • Kontakt:
      • Goyang-si, Gyeonggi-do, Südkorea, 10326
        • Noch keine Rekrutierung
        • Dongguk University Ilsan Hospital
        • Kontakt:
          • Hansu Assistant professor, MD.
          • Telefonnummer: 080-10-6326-1641
          • E-Mail: hsbae81@gmail.com

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • Adult male and female patients aged 19 to 65 years scheduled for surgery under general anesthesia.
  • Patients scheduled for surgery in areas that do not affect ECG electrode placement (e.g., abdomen, head, face, lower limbs).
  • Patients with normal or abnormal ST segment changes confirmed on preoperative ECG.

Exclusion Criteria:

  • Patients who do not consent to the study.
  • Patients with implanted pacemakers.
  • Patients with a history of heart or lung surgery.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Diagnose
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: All Participants
All enrolled patients (n=84) undergoing general anesthesia without restrictions on ECG lead placement receive simultaneous ECG monitoring with three lead configurations: standard Lead II (baseline), left-side modified sternum-chest Lead II (mSC2), and left-side modified temple-chest Lead II (mTC2) post-induction. Right-side versions are added post-surgery. This single arm tests ST segment similarity across methods to improve intraoperative cardiac monitoring accuracy
Gerät: Standard
Standard ECG Lead II monitoring: Three electrodes placed on both clavicles below and left anterior superior iliac spine (outside heart boundary). Recorded simultaneously post-induction for at least 10 noise-free waves using Vital Recorder software to establish baseline ST segment morphology during general anesthesia."
Andere Namen:
  • mSC2
  • mTC2
Gerät: mSC2
Modified Sternum-Chest Lead II ECG (mSC2): Electrode relocated to sternum center (replacing left shoulder), with right shoulder and left anterior superior iliac spine. Left-side version recorded post-induction; right-side post-surgery. Assesses ST segment similarity to standard for accurate ischemia detection in anesthesia.
Gerät: mTC2
Modified Temple-Chest Lead II ECG (mTC2): Electrode relocated near temple (replacing left shoulder), with right shoulder and left anterior superior iliac spine. Left-side version recorded post-induction; right-side post-surgery. Evaluates ST segment morphology match to standard to enhance cardiac monitoring reliability.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Percentage of participants for whom each modified Lead II configuration demonstrates superior visual similarity to the Standard Lead II
Zeitfenster: Periprocedural
This measure evaluates and compares which of the two modified Lead II configurations (Left modified Temple-Chest Lead II [Lt-mTC2] vs. Left modified Sternum-Chest Lead II [Lt-mSC2]) aligns more accurately with the Standard Lead II. To ensure objectivity, two blinded researchers will independently compare the ECG waveform shapes and determine which modified lead shows superior visual similarity to the Standard Lead II. In cases of disagreement or tie, a third researcher will re-evaluate the waveforms for the final decision. Evaluators will be strictly blinded to the identity of the specific leads being assessed.
Periprocedural

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Percentage of participants for whom each right-side modified Lead II configuration demonstrates superior visual similarity to the Standard Lead II
Zeitfenster: Periprocedural
This measure evaluates and compares which of the two right-side modified Lead II configurations (Right modified Temple-Chest Lead II [Rt-mTC2] vs. Right modified Sternum-Chest Lead II [Rt-mSC2]) aligns more accurately with the Standard Lead II post-surgery. Two blinded researchers will independently compare the ECG waveform shapes and determine which right-side modified lead shows superior visual similarity to the Standard Lead II. In cases of disagreement or tie, a third researcher will re-evaluate the waveforms for the final decision. Evaluators will be strictly blinded to the identity of the specific leads.
Periprocedural
Mean difference in ST segment amplitude between modified Temple-Chest Lead II (mTC2) and Standard Lead II
Zeitfenster: Periprocedural
The quantitative difference in ST segment amplitude (measured in millimeters or millivolts) will be compared between the mTC2 configuration and the Standard Lead II. Waveform data will be processed using R and RStudio programs to calculate the absolute amplitude differences. A paired t-test will be performed to analyze the statistical agreement and determine if significant differences exist between the two leads.
Periprocedural
Mean difference in ST segment amplitude between modified Sternum-Chest Lead II (mSC2) and Standard Lead II
Zeitfenster: Periprocedural
The quantitative difference in ST segment amplitude (measured in millimeters or millivolts) will be compared between the mSC2 configuration and the Standard Lead II. Waveform data will be processed using R and RStudio programs to calculate the absolute amplitude differences. A paired t-test will be performed to analyze the statistical agreement and determine if significant differences exist between the two leads.
Periprocedural

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Hansu Bae

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

25. Februar 2026

Primärer Abschluss (Geschätzt)

17. Dezember 2026

Studienabschluss (Geschätzt)

5. November 2027

Studienanmeldedaten

Zuerst eingereicht

15. November 2025

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

19. Juli 2026

Zuerst gepostet (Tatsächlich)

22. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

22. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

19. Juli 2026

Zuletzt verifiziert

1. Juli 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • DUIH IRB 2025-12-018

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

No plan to share individual participant data to protect participant privacy.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren